F
BTAL icon

FolioMetrix’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

FolioMetrix’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$971K Buy
+48,850
New +$945K 0.41% 51

Other funds holding BTAL

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

FolioMetrix's BTAL Position: Q2 2015 in Review

FolioMetrix opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2015: 48,850 shares worth $971K. The stake represents 0.41% of the portfolio and ranks #51 among its holdings.

6 funds tracked by Wall St. Rank hold BTAL as of Q2 2015.

  • FolioMetrix held 48,850 shares of AGF US Market Neutral Anti-Beta Fund worth $971K as of Q2 2015.
  • AGF US Market Neutral Anti-Beta Fund was a new FolioMetrix position in Q2 2015.
  • AGF US Market Neutral Anti-Beta Fund made up 0.41% of FolioMetrix's portfolio in Q2 2015, its #51 holding.
  • 6 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.